Healthcare provider profile · identity verified

Keith Johnson, MD

Family Practice · MAPLE GROVE, MN · NPI 1013412956

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	717	212
Lisinopril	Lisinopril	333	96
Amlodipine Besylate	Amlodipine Besylate	301	93
Losartan Potassium	Losartan Potassium	228	75
Levothyroxine Sodium	Levothyroxine Sodium	205	56
Rosuvastatin Calcium	Rosuvastatin Calcium	200	62
Metoprolol Succinate	Metoprolol Succinate	175	58
Tamsulosin Hcl	Tamsulosin Hcl	165	56
Metformin Hcl Er	Metformin Hcl	163	48
Hydrochlorothiazide	Hydrochlorothiazide	158	48
Simvastatin	Simvastatin	144	40
Omeprazole	Omeprazole	137	43
Allopurinol	Allopurinol	98	29
Gabapentin	Gabapentin	90	30
Metformin Hcl	Metformin Hcl	84	28
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	80	23
Jardiance	Empagliflozin	70	24
Warfarin Sodium	Warfarin Sodium	64	18
Clopidogrel	Clopidogrel Bisulfate	63	16
Trazodone Hcl	Trazodone Hcl	62	22
Furosemide	Furosemide	61	19
Metoprolol Tartrate	Metoprolol Tartrate	60	16
Duloxetine Hcl	Duloxetine Hcl	56	15
Pantoprazole Sodium	Pantoprazole Sodium	50	18
Atenolol	Atenolol	46	13
Escitalopram Oxalate	Escitalopram Oxalate	44	17
Glimepiride	Glimepiride	44	12
Triamcinolone Acetonide	Triamcinolone Acetonide	42	23
Eliquis	Apixaban	40	14
Finasteride	Finasteride	39	suppressed
Montelukast Sodium	Montelukast Sodium	39	14
Ozempic	Semaglutide	37	12
Fluoxetine Hcl	Fluoxetine Hcl	35	suppressed
Chlorthalidone	Chlorthalidone	32	11
Citalopram Hbr	Citalopram Hydrobromide	32	11
Ezetimibe	Ezetimibe	31	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	31	suppressed
Pravastatin Sodium	Pravastatin Sodium	31	12
Prednisone	Prednisone	31	21
Isosorbide Mononitrate Er	Isosorbide Mononitrate	30	suppressed
Bupropion Xl	Bupropion Hcl	29	suppressed
Sertraline Hcl	Sertraline Hcl	29	11
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	28	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	27	12
Januvia	Sitagliptin Phosphate	27	suppressed
Famotidine	Famotidine	26	suppressed
Xarelto	Rivaroxaban	26	suppressed
Breo Ellipta	Fluticasone/Vilanterol	21	suppressed
Carvedilol	Carvedilol	21	suppressed
Nitroglycerin	Nitroglycerin	21	13
Fluticasone Propionate	Fluticasone Propionate	20	suppressed
Glipizide	Glipizide	20	suppressed
Potassium Chloride	Potassium Chloride	20	suppressed
Alprazolam	Alprazolam	18	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	18	suppressed
Ventolin Hfa	Albuterol Sulfate	18	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	17	suppressed
Humalog Kwikpen U-100	Insulin Lispro	17	suppressed
Spironolactone	Spironolactone	17	suppressed
Tramadol Hcl	Tramadol Hcl	17	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	16	suppressed
Torsemide	Torsemide	16	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	16	suppressed
Alendronate Sodium	Alendronate Sodium	15	suppressed
Pregabalin	Pregabalin	15	suppressed
Spiriva Respimat	Tiotropium Bromide	15	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	14	14
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	14	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	14	suppressed
Klor-Con M20	Potassium Chloride	14	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	14	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	14	suppressed
Carbamazepine Er	Carbamazepine	13	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	13	suppressed
Nifedipine Er	Nifedipine	13	suppressed
Paroxetine Hcl	Paroxetine Hcl	13	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	13	suppressed
Fenofibrate	Fenofibrate	12	suppressed
Trulicity	Dulaglutide	12	suppressed
Atrovent Hfa	Ipratropium Bromide	11	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	11	suppressed
Methocarbamol	Methocarbamol	11	suppressed
Mirtazapine	Mirtazapine	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error